@mvalma

Director @UpperGIPadova, Padova University Hospital - Ass Professor of Surgery @UniPadova. Husband, Shih Tzu lover, photographer, Apple fanboy.

 Italy/Padova
centroesofagopadova.org
Joined July 2009
  • Tweets149
  • Following159
  • Followers114
5Media
Michele Valmasoni MD PhD FACS retweeted
JAMA Surgery@JAMASurgeryJan 23
Standard esophagectomy after neoadjuvant chemoradiation may provide greater long-term survival and quality-of-life benefits than active surveillance for most patients with esophageal cancer. ja.ma/4sPlBNb
2
11
2
41
9,210
Michele Valmasoni MD PhD FACS retweeted
ASCO
@ASCOJan 8
Delving into the“Organ Preservation for Gastroesophageal Junction & Gastric Adenocarcinoma: Ready for Primetime?” w co-chairs Drs. Daniel Tandel Chang & Ugwuji Maduekwe @ #GI26. Case-based discussions w/ opposing views. 🔥 #esocsm brnw.ch/21wYVT0 @Daniela_Molena @IkomaMD
2
1
4
1,455
Michele Valmasoni MD PhD FACS retweeted
Jessie Elliott@JessieAElliottJan 5
Pleased to contribute to this study with colleagues from across Europe @stjamesdublin @CancerInstIRE - care for pts with major UGI emergency conditions remains an important aspect of our unit's work @nicraftery @BJSurgery doi.org/10.1093/bjs/znaf260

Treatment strategies for Boerhaave syndrome: multinational retrospective cohort study

This study provides a comprehensive overview of the current treatment strategies and outcomes for patients with Boerhaave syndrome in Europe.

academic.oup.com
2
9
290
Michele Valmasoni MD PhD FACS retweeted
JAMA Surgery@JAMASurgery25 Nov 2025
Patients who received robot-assisted surgery vs conventional laparoscopic surgery had a higher incidence of postoperative pulmonary complications and received longer and more intense mechanical ventilation. ja.ma/3JZ0p62
19
2
57
8,914
Michele Valmasoni MD PhD FACS retweeted
TheTeslaLife
@TheTeslaLife23 Nov 2025
The Rise and Fall of Oil carswithcords.net/2025/11/th…
2
5
1
17
1,830
Michele Valmasoni MD PhD FACS retweeted
JAMA Surgery@JAMASurgery30 Oct 2025
Robotic hiatal hernia repair offered no short-term morbidity or mortality advantage over laparoscopic hiatal hernia repair but incurred longer operative times and a higher pulmonary embolism risk in older adults. ja.ma/4qEFHc8
1
11
40
4,788
Michele Valmasoni MD PhD FACS retweeted
Annals of Surgical Oncology@AnnSurgOncol14 Oct 2025
October Issue: Thoracic Duct Resection in Robotic #Esophagectomy : Precision Without Clear Benefit @sgworrell rdcu.be/eJT7S @AndrewFlemingMD @SyedAAhmad5
2
5
667
Michele Valmasoni MD PhD FACS retweeted
Università di Padova@UniPadova8 Oct 2025
🏥 Inaugurato il Nuovo Ospedale Pediatrico del Veneto “Salus Pueri”. Una struttura moderna, ispirata alla natura, che unisce cura, ricerca e formazione unipd.link/inaugurazione-nuo…
1
3
5
1,417
Steven Paul Jobs. 1955 - 2011 stevejobsarchive.com

The Steve Jobs Archive

The Steve Jobs Archive is the authoritative home for Steve’s story and a resource to help new generations make their own mark.

stevejobsarchive.com
21
nr.apple.com/Dh8W2n0Us9

The Digital Markets Act’s impacts on EU users

Apple explains how the Digital Markets Act is forcing the company to make some concerning changes to how it designs and delivers Apple products to its users in Europe.

apple.com
24
Michele Valmasoni MD PhD FACS retweeted
Sheraz Markar@MarkarSheraz6 Jul 2025
SANO trial: innovations, risks, and unanswered questions - felt very strongly along with several UGI colleagues we must highlight the important limitations of the SANO trial and thus counsel our patients appropriately regarding these results! ⁦ thelancet.com/journals/lanon…

SANO trial: innovations, risks, and unanswered questions

Despite the obvious interest in an organ preservation strategy for oesophageal cancer, the SANO trial, published in the report by Berend J van der Wilk and colleagues,1 has important limitations,...

thelancet.com
9
1
17
1,928
Prognostic Value of Tumor Regression Grade After Chemotherapy Versus Chemoradiotherapy in Patients Undergoing Neoad… pubmed.ncbi.nlm.nih.gov/4032…

Prognostic Value of Tumor Regression Grade After Chemotherapy Versus Chemoradiotherapy in Patients...

Tumor regression grade was significantly associated with survival after NACT, but not with NACRT. Despite a lower rate of pCR, both OS and, especially, DFS of patients with pCR improved after NACT...

pubmed.ncbi.nlm.nih.gov
61
Michele Valmasoni MD PhD FACS retweeted
Shahin Ayazi
@Sayazi7 May 2025
Great discussion at the SSAT–Women in Thoracic Surgery Joint Symposium on controversies in esophageal and GEJ malignancies. A thoughtful, multidisciplinary exchange on some of the most challenging questions in foregut oncology. #DDW2025 #SSAT2025 @WomenInThoracic @SSATNews @sgworrell @docstephwood @Daniela_Molena @mvalma
2
6
19
1,492
Michele Valmasoni MD PhD FACS retweeted
Annals of Surgery@AnnalsofSurgery22 Mar 2025
Real-world application of endoscopic resection for early-stage esophageal cancer: do we need to rethink the guidelines? journals.lww.com/annalsofsur…
5
1
14
2,702
Michele Valmasoni MD PhD FACS retweeted
NEJM
@NEJM22 Jan 2025
ESOPEC, a large randomized trial involving patients with resectable esophageal cancer, showed that perioperative chemotherapy improved overall survival as compared with preoperative chemoradiotherapy. Full trial results: nej.md/4apWlo5 Editorial: Multimodal Treatment in Locally Advanced Esophageal Adenocarcinoma — Two Interventions Better Than Three? nej.md/40rpHhl
Graphs showing overall survival (primary end point) (Panel A) and progression-free survival (Panel B).

ALT Graphs showing overall survival (primary end point) (Panel A) and progression-free survival (Panel B).

2
54
6
128
27,020
Michele Valmasoni MD PhD FACS retweeted
Tim Cook
@tim_cook5 Oct 2024
Steve showed us that the future isn’t something you wait for—it’s something you build. His memory lives on in the hearts of innovators and dreamers everywhere—at Apple and beyond.
A black and white portrait of Steve smiling in glasses and a black turtleneck from 2007.

ALT A black and white portrait of Steve smiling in glasses and a black turtleneck from 2007.

1,822
6,150
601
47,869
2,162,900
Michele Valmasoni MD PhD FACS retweeted
Lorenzo Ferri MD PhD@LFerri1232 Apr 2024
Great work by ⁦@JamieTankel⁩ demonstrating that non-regional retroperitoneal nodes in gastro-esophageal adeno can be treated successfully with curative intent surgery in select cases. ⁦@JournalofGISurg⁩ ⁦@SSATNews⁩ sciencedirect.com/science/ar…
5
9
3
22
5,330
Michele Valmasoni MD PhD FACS retweeted
Università di Padova@UniPadova9 Feb 2024
Abbiamo inaugurato l'802° a.a. #Unipd con la rettrice Mapelli, il ministro Carlo Nordio @minGiustizia, il direttore generale @ascuttari , la presidente del consiglio degli studenti Emma Ruzzon e la prolusione di Simone Montangero @DFAUnipd > unipd.link/inaugurazione-802…
1
5
7
723
Michele Valmasoni MD PhD FACS retweeted
European Journal of Surgical Oncology@ejsotweets16 Jan 2024
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series @ESSOnews @EYSAC1 @RovielloFranco @AndreasBrandl8 @me4_so #GastricCancer #SurgOnc #GIRCG bit.ly/3vwc3xq
3
10
1,124
Load more